BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25075031)

  • 1. Silencing of phosphoinositide-specific phospholipase C ε remodulates the expression of the phosphoinositide signal transduction pathway in human osteosarcoma cell lines.
    Lo Vasco VR; Leopizzi M; Stoppoloni D; Della Rocca C
    Anticancer Res; 2014 Aug; 34(8):4069-75. PubMed ID: 25075031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines.
    Lo Vasco VR; Leopizzi M; Puggioni C; Della Rocca C
    J Cell Commun Signal; 2014 Sep; 8(3):219-29. PubMed ID: 25073508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin-related Phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines.
    Lo Vasco VR; Leopizzi M; Della Rocca C
    J Cell Commun Signal; 2015 Mar; 9(1):55-62. PubMed ID: 25618778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U-73122 reduces the cell growth in cultured MG-63 ostesarcoma cell line involving Phosphoinositide-specific Phospholipases C.
    Lo Vasco VR; Leopizzi M; Di Maio V; Della Rocca C
    Springerplus; 2016; 5():156. PubMed ID: 27026853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin, a key component in tumor metastasis.
    Hunter KW
    Trends Mol Med; 2004 May; 10(5):201-4. PubMed ID: 15121044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell lines.
    Lo Vasco VR; Leopizzi M; Chiappetta C; Puggioni C; Di Cristofano C; Della Rocca C
    J Cell Commun Signal; 2013 Jun; 7(2):141-50. PubMed ID: 23430511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of phosphoinositide-specific phospholipase C enzymes in human skin fibroblasts.
    Lo Vasco VR; Leopizzi M; Chiappetta C; Puggioni C; Di Cristofano C; Della Rocca C
    Connect Tissue Res; 2013; 54(1):1-4. PubMed ID: 22800439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
    Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell.
    Zhang J; Zuo J; Lei M; Wu S; Zang X; Zhang C
    Chin Med J (Engl); 2014; 127(10):1954-9. PubMed ID: 24824262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers.
    Martins M; McCarthy A; Baxendale R; Guichard S; Magno L; Kessaris N; El-Bahrawy M; Yu P; Katan M
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4239-44. PubMed ID: 24591640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
    Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
    Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants.
    Sorli SC; Bunney TD; Sugden PH; Paterson HF; Katan M
    Oncogene; 2005 Jan; 24(1):90-100. PubMed ID: 15558028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
    Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
    Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of phosphoinositide-specific phospholipase C isoenzymes in cultured astrocytes activated after stimulation with lipopolysaccharide.
    Lo Vasco VR; Fabrizi C; Fumagalli L; Cocco L
    J Cell Biochem; 2010 Apr; 109(5):1006-12. PubMed ID: 20082315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.
    Zucchini C; Manara MC; Pinca RS; De Sanctis P; Guerzoni C; Sciandra M; Lollini PL; Cenacchi G; Picci P; Valvassori L; Scotlandi K
    Oncogene; 2014 Apr; 33(15):1912-21. PubMed ID: 23644663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis.
    Ogino W; Takeshima Y; Mori T; Yanai T; Hayakawa A; Akisue T; Kurosaka M; Matsuo M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):435-9. PubMed ID: 17609619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels.
    Nebigil CG
    Biochemistry; 1997 Dec; 36(50):15949-58. PubMed ID: 9398329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.